Format
Items per page
Sort by

Send to:

Choose Destination

Results: 9

Related Articles by Review for PubMed (Select 19264769)

1.

Enhanced exposure of the CD4-binding site to neutralizing antibodies by structural design of a membrane-anchored human immunodeficiency virus type 1 gp120 domain.

Wu L, Zhou T, Yang ZY, Svehla K, O'Dell S, Louder MK, Xu L, Mascola JR, Burton DR, Hoxie JA, Doms RW, Kwong PD, Nabel GJ.

J Virol. 2009 May;83(10):5077-86. doi: 10.1128/JVI.02600-08. Epub 2009 Mar 4.

2.

GP120: target for neutralizing HIV-1 antibodies.

Pantophlet R, Burton DR.

Annu Rev Immunol. 2006;24:739-69. Review.

PMID:
16551265
3.

In search of a better HIV vaccine - the heat is on.

Phimister EG.

N Engl J Med. 2003 Feb 13;348(7):643-4. Review. No abstract available.

PMID:
12584375
4.

Elicitation of HIV-1-neutralizing antibodies against the CD4-binding site.

Georgiev IS, Gordon Joyce M, Zhou T, Kwong PD.

Curr Opin HIV AIDS. 2013 Sep;8(5):382-92. doi: 10.1097/COH.0b013e328363a90e. Review.

5.

Back to the future: covalent epitope-based HIV vaccine development.

Paul S, Planque S, Nishiyama Y, Escobar M, Hanson C.

Expert Rev Vaccines. 2010 Sep;9(9):1027-43. doi: 10.1586/erv.10.77. Review.

6.

Antibody vs. HIV in a clash of evolutionary titans.

Burton DR, Stanfield RL, Wilson IA.

Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):14943-8. Epub 2005 Oct 11. Review.

7.

Protective versus pathogenic anti-CD4 immunity: insights from the study of natural resistance to HIV infection.

Burastero SE, Figini M, Frigerio B, Lusso P, Mollica L, Lopalco L.

J Transl Med. 2009 Nov 28;7:101. doi: 10.1186/1479-5876-7-101. Review.

8.

Candidate antibody-based therapeutics against HIV-1.

Gong R, Chen W, Dimitrov DS.

BioDrugs. 2012 Jun 1;26(3):143-62. doi: 10.2165/11631400-000000000-00000. Review.

PMID:
22462520
9.

Design of miniproteins by the transfer of active sites onto small-size scaffolds.

Stricher F, Martin L, Vita C.

Methods Mol Biol. 2006;340:113-49. Review.

PMID:
16957335
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk